Tuesday, July 07, 2020 1:39:45 PM
It was an application for an Orphan Drug Indication in 2015. At that time it didn't make sense to have it under that classification.
The Phase 3 bucillamine for Covid is a whole new ballgame.
Apples and oranges...
The Phase 3 bucillamine for Covid is a whole new ballgame.
Apples and oranges...
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
